Toshio Shimizu1, Yuki Nakayama2, Chiharu Matsuda2, Michiko Haraguchi2, Kota Bokuda3, Kazuko Ishikawa-Takata4, Akihiro Kawata3, Eiji Isozaki3. 1. Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, Tokyo, 183-0042, Japan. toshio_shimizu@tmhp.jp. 2. ALS Nursing Care Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan. 3. Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, Tokyo, 183-0042, Japan. 4. Department of Nutritional Education, National Institute of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.
Abstract
BACKGROUND: Body weight reduction after disease onset is an independent predictor of survival in amyotrophic lateral sclerosis (ALS), but significance of weight variation after diagnosis remains to be established. OBJECTIVE: To investigate weight variation after diagnosis and its prognostic significance in patients with ALS as a prospective cohort study. METHODS: Seventy-nine patients with ALS were enrolled in this study. At the time of diagnosis and about 1 year later, we evaluated the following parameters: age, sex, onset age, onset region, body mass index (BMI) and premorbid BMI, forced vital capacity and the revised ALS functional rating scale. Annual BMI decline rates (∆BMI) from onset to diagnosis and from diagnosis to about 1 year later were calculated. Patients were followed to the endpoints (death or tracheostomy), and the relationships between ∆BMIs and survival were investigated. RESULTS: Patients with post-diagnostic ∆BMI ≥ 2.0 kg/m2/year showed shorter survival length than those with < 2.0 kg/m2/year (log-rank test, p < 0.0001), and multivariate analysis using the Cox model revealed post-diagnostic ∆BMI as an independent prognostic factor. No correlation was identified between pre- and post-diagnostic ∆BMIs. Female patients with post-diagnostic ∆BMI < pre-diagnostic ∆BMI showed longer survival than those with the opposite ∆BMI trend (log-rank test, p = 0.0147). Female patients with post-diagnostic weight increase showed longer survival than those with weight decrease (log-rank test, p = 0.0228). CONCLUSION: Body weight changes after diagnosis strongly predicts survival in ALS, and weight gain after diagnosis may improve survival prognosis, particularly in female ALS patients.
BACKGROUND: Body weight reduction after disease onset is an independent predictor of survival in amyotrophic lateral sclerosis (ALS), but significance of weight variation after diagnosis remains to be established. OBJECTIVE: To investigate weight variation after diagnosis and its prognostic significance in patients with ALS as a prospective cohort study. METHODS: Seventy-nine patients with ALS were enrolled in this study. At the time of diagnosis and about 1 year later, we evaluated the following parameters: age, sex, onset age, onset region, body mass index (BMI) and premorbid BMI, forced vital capacity and the revised ALS functional rating scale. Annual BMI decline rates (∆BMI) from onset to diagnosis and from diagnosis to about 1 year later were calculated. Patients were followed to the endpoints (death or tracheostomy), and the relationships between ∆BMIs and survival were investigated. RESULTS: Patients with post-diagnostic ∆BMI ≥ 2.0 kg/m2/year showed shorter survival length than those with < 2.0 kg/m2/year (log-rank test, p < 0.0001), and multivariate analysis using the Cox model revealed post-diagnostic ∆BMI as an independent prognostic factor. No correlation was identified between pre- and post-diagnostic ∆BMIs. Female patients with post-diagnostic ∆BMI < pre-diagnostic ∆BMI showed longer survival than those with the opposite ∆BMI trend (log-rank test, p = 0.0147). Female patients with post-diagnostic weight increase showed longer survival than those with weight decrease (log-rank test, p = 0.0228). CONCLUSION: Body weight changes after diagnosis strongly predicts survival in ALS, and weight gain after diagnosis may improve survival prognosis, particularly in female ALS patients.
Entities:
Keywords:
Amyotrophic lateral sclerosis; Body weight; Nutritional intervention; Sex difference; Survival
Authors: B Marin; J C Desport; P Kajeu; P Jesus; B Nicolaud; M Nicol; P M Preux; P Couratier Journal: J Neurol Neurosurg Psychiatry Date: 2010-11-19 Impact factor: 10.154
Authors: Edward J Kasarskis; Marta S Mendiondo; Dwight E Matthews; Hiroshi Mitsumoto; Rup Tandan; Zachary Simmons; Mark B Bromberg; Richard J Kryscio Journal: Am J Clin Nutr Date: 2014-02-12 Impact factor: 7.045
Authors: C Bouteloup; J-C Desport; P Clavelou; N Guy; H Derumeaux-Burel; A Ferrier; P Couratier Journal: J Neurol Date: 2009-03-22 Impact factor: 4.849
Authors: Frederik J Steyn; Zara A Ioannides; Ruben P A van Eijk; Susan Heggie; Kathryn A Thorpe; Amelia Ceslis; Saman Heshmat; Anjali K Henders; Naomi R Wray; Leonard H van den Berg; Robert D Henderson; Pamela A McCombe; Shyuan T Ngo Journal: J Neurol Neurosurg Psychiatry Date: 2018-04-29 Impact factor: 10.154
Authors: Teresa Holm; André Maier; Paul Wicks; Dirk Lang; Peter Linke; Christoph Münch; Laura Steinfurth; Robert Meyer; Thomas Meyer Journal: Interact J Med Res Date: 2013-04-17
Authors: Juan Miguel Godoy-Corchuelo; Luis C Fernández-Beltrán; Zeinab Ali; María J Gil-Moreno; Juan I López-Carbonero; Antonio Guerrero-Sola; Angélica Larrad-Sainz; Jorge Matias-Guiu; Jordi A Matias-Guiu; Thomas J Cunningham; Silvia Corrochano Journal: Biomedicines Date: 2022-05-10